Trial Search Results

Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

This pilot clinical trial studies imaging during surgery in diagnosing patients with prostate, bladder, or kidney cancer. New diagnostic imaging procedures, may find prostate, bladder, or kidney cancer

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Cancer Institute (NCI)


  • Procedure: photoacoustic imaging
  • Procedure: fluorescence imaging
  • Procedure: robot-assisted laparoscopic surgery




Inclusion Criteria:

   - Patients must have a pathologic confirmation of prostate cancer, bladder cancer, or
   kidney cancer based on previous biopsies or procedures OR a strong concern for a
   kidney malignancy based on computed tomography (CT) or magnetic resonance imaging
   (MRI) imaging

   - Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

   - Patients with a surgical history or anatomic variant that would preclude robot
   assisted laparoscopic approaches to their surgery (i.e. history of ventral hernia
   repair with mesh)

   - Patients with medical co-morbidities who cannot tolerate laparoscopic surgery
   secondary to intra-abdominal carbon dioxide insufflation

   - Patients with documented allergy or adverse drug reaction to indocyanine green or
   baseline serum creatinine greater than 1.5 mg/dL

Ages Eligible for Study

18 Years - 85 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Mark Gonzalgo
Not Recruiting